Skip to main content

Trinity College Dublin, The University of Dublin

Trinity Menu Trinity Search



You are here People

Prof Orla Hardiman

Publications list (last 4 years)

  1. Byrne, S., Heverin, M., Elamin, M., Walsh, C., and Hardiman, O. (2014) Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis & frontotemporal degeneration 15, 148-150.
  2. Diekstra, F. P., Van Deerlin, V. M., van Swieten, J. C., Al-Chalabi, A., Ludolph, A. C., Weishaupt, J. H., Hardiman, O., Landers, J. E., Brown, R. H., Jr., van Es, M. A., Pasterkamp, R. J., Koppers, M., Andersen, P. M., Estrada, K., Rivadeneira, F., Hofman, A., Uitterlinden, A. G., van Damme, P., Melki, J., Meininger, V., Shatunov, A., Shaw, C. E., Leigh, P. N., Shaw, P. J., Morrison, K. E., Fogh, I., Chio, A., Traynor, B. J., Czell, D., Weber, M., Heutink, P., de Bakker, P. I., Silani, V., Robberecht, W., van den Berg, L. H., and Veldink, J. H. (2014) C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome-wide meta-analysis, Annals of neurology.
  3. Fahey, C., Byrne, S., McLaughlin, R., Kenna, K., Shatunov, A., Donohoe, G., Gill, M., Al-Chalabi, A., Bradley, D. G., Hardiman, O., Corvin, A. P., and Morris, D. W. (2014) Analysis of the hexanucleotide repeat expansion and founder haplotype at C9ORF72 in an Irish psychosis case-control sample, Neurobiol Aging 35, 1510 e1511-1515.
  4. Fogh, I., Ratti, A., Gellera, C., Lin, K., Tiloca, C., Moskvina, V., Corrado, L., Soraru, G., Cereda, C., Corti, S., Gentilini, D., Calini, D., Castellotti, B., Mazzini, L., Querin, G., Gagliardi, S., Del Bo, R., Conforti, F. L., Siciliano, G., Inghilleri, M., Sacca, F., Bongioanni, P., Penco, S., Corbo, M., Sorbi, S., Filosto, M., Ferlini, A., Di Blasio, A. M., Signorini, S., Shatunov, A., Jones, A., Shaw, P. J., Morrison, K. E., Farmer, A. E., Van Damme, P., Robberecht, W., Chio, A., Traynor, B. J., Sendtner, M., Melki, J., Meininger, V., Hardiman, O., Andersen, P. M., Leigh, N. P., Glass, J. D., Overste, D., Diekstra, F. P., Veldink, J. H., van Es, M. A., Shaw, C. E., Weale, M. E., Lewis, C. M., Williams, J., Brown, R. H., Landers, J. E., Ticozzi, N., Ceroni, M., Pegoraro, E., Comi, G. P., D'Alfonso, S., van den Berg, L. H., Taroni, F., Al-Chalabi, A., Powell, J., Silani, V., Consortium, S., Collaborators, and Consortium, I. (2014) A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis, Human molecular genetics 23, 2220-2231.
  5. Foley, G., Timonen, V., and Hardiman, O. (2014) Understanding psycho-social processes underpinning engagement with services in motor neurone disease: a qualitative study, Palliative medicine 28, 318-325.
  6. Foley, G., Timonen, V., and Hardiman, O. (2014) Exerting control and adapting to loss in amyotrophic lateral sclerosis, Social science & medicine (1982) 101, 113-119.
  7. Foley, G., Timonen, V., and Hardiman, O. (2014) Acceptance and decision making in amyotrophic lateral sclerosis from a life-course perspective, Qualitative health research 24, 67-77.
  8. Goris, A., van Setten, J., Diekstra, F., Ripke, S., Patsopoulos, N. A., Sawcer, S. J., International Multiple Sclerosis Genetics, C., van Es, M., Australia, New Zealand, M. S. G. C., Andersen, P. M., Melki, J., Meininger, V., Hardiman, O., Landers, J. E., Brown, R. H., Jr., Shatunov, A., Leigh, N., Al-Chalabi, A., Shaw, C. E., Traynor, B. J., Chio, A., Restagno, G., Mora, G., Ophoff, R. A., Oksenberg, J. R., Van Damme, P., Compston, A., Robberecht, W., Dubois, B., van den Berg, L. H., De Jager, P. L., Veldink, J. H., and de Bakker, P. I. (2014) No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis, Human molecular genetics 23, 1916-1922.
  9. McLaughlin, R. L., Kenna, K. P., Vajda, A., Byrne, S., Bradley, D. G., and Hardiman, O. (2014) UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in Ireland, Neurobiol Aging 35, 267 e269-211.
  10. Murray, D., Hardiman, O., and Meldrum, D. (2014) Assessment of subjective and motor fatigue in Polio survivors, attending a Postpolio clinic, comparison with healthy controls and an exploration of clinical correlates, Physiotherapy theory and practice 30, 229-235.
  11. Pupillo, E., Messina, P., Giussani, G., Logroscino, G., Zoccolella, S., Chio, A., Calvo, A., Corbo, M., Lunetta, C., Marin, B., Mitchell, D., Hardiman, O., Rooney, J., Stevic, Z., Bandettini di Poggio, M., Filosto, M., Cotelli, M. S., Perini, M., Riva, N., Tremolizzo, L., Vitelli, E., Damiani, D., Beghi, E., and Consortium, E. (2014) Physical activity and amyotrophic lateral sclerosis: A European population-based case-control study, Annals of neurology 75, 708-716.
  12. Rooney, J., Heverin, M., Vajda, A., Crampsie, A., Tobin, K., Byrne, S., Staines, A., and Hardiman, O. (2014) An Exploratory Spatial Analysis of ALS Incidence in Ireland over 17.5 Years (1995 - July 2013), PLoS One 9, e96556.
  13. van Doormaal, P. T., Ticozzi, N., Gellera, C., Ratti, A., Taroni, F., Chio, A., Calvo, A., Mora, G., Restagno, G., Traynor, B. J., Birve, A., Lemmens, R., van Es, M. A., Saris, C. G., Blauw, H. M., van Vught, P. W., Groen, E. J., Corrado, L., Mazzini, L., Del Bo, R., Corti, S., Waibel, S., Meyer, T., Ludolph, A. C., Goris, A., van Damme, P., Robberecht, W., Shatunov, A., Fogh, I., Andersen, P. M., D'Alfonso, S., Hardiman, O., Cronin, S., Rujescu, D., Al-Chalabi, A., Landers, J. E., Silani, V., van den Berg, L. H., and Veldink, J. H. (2014) Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study, Neurobiol Aging 35, 2420 e2413-2424.
  14. van Rheenen, W., Diekstra, F. P., van Doormaal, P. T., Seelen, M., Kenna, K., McLaughlin, R., Shatunov, A., Czell, D., van Es, M. A., van Vught, P. W., van Damme, P., Smith, B. N., Waibel, S., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., Weber, M., Robberecht, W., Hardiman, O., Shaw, P. J., Shaw, C. E., Morrison, K. E., Al-Chalabi, A., Andersen, P. M., Ludolph, A. C., Veldink, J. H., and van den Berg, L. H. (2013) H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis, Neurobiol Aging 34, 1517 e1515-1517.
  15. Turner, M. R., Hardiman, O., Benatar, M., Brooks, B. R., Chio, A., de Carvalho, M., Ince, P. G., Lin, C., Miller, R. G., Mitsumoto, H., Nicholson, G., Ravits, J., Shaw, P. J., Swash, M., Talbot, K., Traynor, B. J., Van den Berg, L. H., Veldink, J. H., Vucic, S., and Kiernan, M. C. (2013) Controversies and priorities in amyotrophic lateral sclerosis, Lancet neurology 12, 310-322.
  16. Rooney, J., Byrne, S., Heverin, M., Corr, B., Elamin, M., Staines, A., Goldacre, B., and Hardiman, O. (2013) Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010, PLoS One 8, e74733.
  17. Kenna, K. P., McLaughlin, R. L., Hardiman, O., and Bradley, D. G. (2013) Using reference databases of genetic variation to evaluate the potential pathogenicity of candidate disease variants, Human mutation 34, 836-841.
  18. Kenna, K. P., McLaughlin, R. L., Byrne, S., Elamin, M., Heverin, M., Kenny, E. M., Cormican, P., Morris, D. W., Donaghy, C. G., Bradley, D. G., and Hardiman, O. (2013) Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing, Journal of medical genetics 50, 776-783.
  19. Group, A. L., Fournier, C., Bedlack, B., Hardiman, O., Heiman-Patterson, T., Gutmann, L., Bromberg, M., Ostrow, L., Carter, G., Kabashi, E., Bertorini, T., Mozaffar, T., Andersen, P., Dietz, J., Gamez, J., Dimachkie, M., Wang, Y., Wicks, P., Heywood, J., Novella, S., Rowland, L. P., Pioro, E., Kinsley, L., Mitchell, K., Glass, J., Sathornsumetee, S., Kwiecinski, H., Baker, J., Atassi, N., Forshew, D., Ravits, J., Conwit, R., Jackson, C., Sherman, A., Dalton, K., Tindall, K., Gonzalez, G., Robertson, J., Phillips, L., Benatar, M., Sorenson, E., Shoesmith, C., Nash, S., Maragakis, N., Moore, D., Caress, J., Boylan, K., Armon, C., Grosso, M., Gerecke, B., Wymer, J., Oskarsson, B., Bowser, R., Drory, V., Shefner, J., Lechtzin, N., Leitner, M., Miller, R., Mitsumoto, H., Levine, T., Russell, J., Sharma, K., Saperstein, D., McClusky, L., MacGowan, D., Licht, J., Verma, A., Strong, M., Lomen-Hoerth, C., Tandan, R., Rivner, M., Kolb, S., Polak, M., Rudnicki, S., Kittrell, P., Quereshi, M., Sachs, G., Pattee, G., Weiss, M., Kissel, J., Goldstein, J., Rothstein, J., Pastula, D., Gleb, L., Ogino, M., Rosenfeld, J., Carmi, E., Oster, C., Barkhaus, P., and Valor, E. (2013) ALS Untangled No. 20: the Deanna protocol, Amyotrophic lateral sclerosis & frontotemporal degeneration 14, 319-323.
  20. Factor-Litvak, P., Al-Chalabi, A., Ascherio, A., Bradley, W., Chio, A., Garruto, R., Hardiman, O., Kamel, F., Kasarskis, E., McKee, A., Nakano, I., Nelson, L. M., and Eisen, A. (2013) Current pathways for epidemiological research in amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis & frontotemporal degeneration 14 Suppl 1, 33-43.
  21. Elamin, M., Bede, P., Byrne, S., Jordan, N., Gallagher, L., Wynne, B., O'Brien, C., Phukan, J., Lynch, C., Pender, N., and Hardiman, O. (2013) Cognitive changes predict functional decline in ALS: a population-based longitudinal study, Neurology 80, 1590-1597.
  22. Cudkowicz, M. E., van den Berg, L. H., Shefner, J. M., Mitsumoto, H., Mora, J. S., Ludolph, A., Hardiman, O., Bozik, M. E., Ingersoll, E. W., Archibald, D., Meyers, A. L., Dong, Y., Farwell, W. R., Kerr, D. A., and investigators, E. (2013) Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial, Lancet neurology 12, 1059-1067.
  23. Consortium, A., Ahmeti, K. B., Ajroud-Driss, S., Al-Chalabi, A., Andersen, P. M., Armstrong, J., Birve, A., Blauw, H. M., Brown, R. H., Bruijn, L., Chen, W., Chio, A., Comeau, M. C., Cronin, S., Diekstra, F. P., Soraya Gkazi, A., Glass, J. D., Grab, J. D., Groen, E. J., Haines, J. L., Hardiman, O., Heller, S., Huang, J., Hung, W. Y., consortium, I., Jaworski, J. M., Jones, A., Khan, H., Landers, J. E., Langefeld, C. D., Leigh, P. N., Marion, M. C., McLaughlin, R. L., Meininger, V., Melki, J., Miller, J. W., Mora, G., Pericak-Vance, M. A., Rampersaud, E., Robberecht, W., Russell, L. P., Salachas, F., Saris, C. G., Shatunov, A., Shaw, C. E., Siddique, N., Siddique, T., Smith, B. N., Sufit, R., Topp, S., Traynor, B. J., Vance, C., van Damme, P., van den Berg, L. H., van Es, M. A., van Vught, P. W., Veldink, J. H., Yang, Y., and Zheng, J. G. (2013) Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1, Neurobiol Aging 34, 357 e357-319.
  24. Byrne, S., Pradhan, F., Ni Dhubhghaill, S., Treacy, M., Cassidy, L., and Hardiman, O. (2013) Blink rate in ALS, Amyotrophic lateral sclerosis & frontotemporal degeneration 14, 291-293.
  25. Byrne, S., Jordan, I., Elamin, M., and Hardiman, O. (2013) Age at onset of amyotrophic lateral sclerosis is proportional to life expectancy, Amyotrophic lateral sclerosis & frontotemporal degeneration 14, 604-607.
  26. Byrne, S., Heverin, M., Elamin, M., Bede, P., Lynch, C., Kenna, K., MacLaughlin, R., Walsh, C., Al Chalabi, A., and Hardiman, O. (2013) Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis, Annals of neurology 74, 699-708.
  27. Bede, P., Elamin, M., Byrne, S., McLaughlin, R. L., Kenna, K., Vajda, A., Pender, N., Bradley, D. G., and Hardiman, O. (2013) Basal ganglia involvement in amyotrophic lateral sclerosis, Neurology 81, 2107-2115.
  28. Bede, P., Bokde, A. L., Byrne, S., Elamin, M., McLaughlin, R. L., Kenna, K., Fagan, A. J., Pender, N., Bradley, D. G., and Hardiman, O. (2013) Multiparametric MRI study of ALS stratified for the C9orf72 genotype, Neurology 81, 361-369.
  29. Bede, P., Bokde, A., Elamin, M., Byrne, S., McLaughlin, R. L., Jordan, N., Hampel, H., Gallagher, L., Lynch, C., Fagan, A. J., Pender, N., Hardiman, O., Teipel, S. J., Wegrzyn, M., Meindl, T., Frisoni, G., Bokde, A. L., Fellgiebel, A., Filippi, M., Hampel, H., Kloppel, S., Hauenstein, K., Ewers, M., Kehoe, E. G., Toomey, J. M., Balsters, J. H., Bokde, A. L., Rose, E. J., Morris, D. W., Fahey, C., Robertson, I. H., Greene, C., O'Doherty, J., Newell, F. N., Garavan, H., McGrath, J., Bokde, A., Tropea, D., Gill, M., Corvin, A. P., Donohoe, G., O'Dwyer, L., Lamberton, F., Bokde, A. L., Ewers, M., Faluyi, Y. O., Tanner, C., Mazoyer, B., O'Neill, D., Bartley, M., Collins, R., Coughlan, T., Prvulovic, D., and Hampel, H. (2013) Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry 84, 766-773.
  30. Bede, P., Bokde, A., Elamin, M., Byrne, S., McLaughlin, R. L., Jordan, N., Hampel, H., Gallagher, L., Lynch, C., Fagan, A. J., Pender, N., and Hardiman, O. (2013) Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality, J Neurol Neurosurg Psychiatry 84, 766-773.
  31. Al-Chalabi, A., and Hardiman, O. (2013) The epidemiology of ALS: a conspiracy of genes, environment and time, Nature reviews. Neurology 9, 617-628.
  32. Van Hoecke, A., Schoonaert, L., Lemmens, R., Timmers, M., Staats, K. A., Laird, A. S., Peeters, E., Philips, T., Goris, A., Dubois, B., Andersen, P. M., Al-Chalabi, A., Thijs, V., Turnley, A. M., van Vught, P. W., Veldink, J. H., Hardiman, O., Van Den Bosch, L., Gonzalez-Perez, P., Van Damme, P., Brown, R. H., Jr., van den Berg, L. H., and Robberecht, W. (2012) EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans, Nature medicine 18, 1418-1422.
  33. Phukan, J., Elamin, M., Bede, P., Jordan, N., Gallagher, L., Byrne, S., Lynch, C., Pender, N., and Hardiman, O. (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study, J Neurol Neurosurg Psychiatry 83, 102-108.
  34. Murray, D., Meldrum, D., Moloney, R., Campion, A., Horgan, F., and Hardiman, O. (2012) The effects of a home-based arm ergometry exercise programme on physical fitness, fatigue and activity in polio survivors: protocol for a randomised controlled trial, BMC neurology 12, 157.
  35. Hardiman, O., and Figlewicz, D. A. (2012) The expansions of ALS, Neurology 79, 842-843.
  36. Hardiman, O. (2012) Multidisciplinary care in ALS: expanding the team, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 13, 165.
  37. Foley, G., Timonen, V., and Hardiman, O. (2012) Patients' perceptions of services and preferences for care in amyotrophic lateral sclerosis: a review, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 13, 11-24.
  38. Foley, G., Timonen, V., and Hardiman, O. (2012) Experience of services as a key outcome in amyotrophic lateral sclerosis (ALS) care: the case for a better understanding of patient experiences, The American journal of hospice & palliative care 29, 362-367.
  39. Fischer, F. U., Scheurich, A., Wegrzyn, M., Schermuly, I., Bokde, A. L., Kloppel, S., Pouwels, P. J., Teipel, S., Yakushev, I., Fellgiebel, A., Bede, P., Bokde, A. L., Byrne, S., Elamin, M., Fagan, A. J., Hardiman, O., Byrne, S., Elamin, M., Bede, P., Shatunov, A., Walsh, C., Corr, B., Heverin, M., Jordan, N., Kenna, K., Lynch, C., McLaughlin, R. L., Iyer, P. M., O'Brien, C., Phukan, J., Wynne, B., Bokde, A. L., Bradley, D. G., Pender, N., Al-Chalabi, A., and Hardiman, O. (2012) Automated tractography of the cingulate bundle in Alzheimer's disease: a multicenter DTI study. J Magn Reson Imaging 36, 84-91.
  40. Elamin, M., Pender, N., Hardiman, O., and Abrahams, S. (2012) Social cognition in neurodegenerative disorders: a systematic review, J Neurol Neurosurg Psychiatry 83, 1071-1079.
  41. Diekstra, F. P., Saris, C. G., van Rheenen, W., Franke, L., Jansen, R. C., van Es, M. A., van Vught, P. W., Blauw, H. M., Groen, E. J., Horvath, S., Estrada, K., Rivadeneira, F., Hofman, A., Uitterlinden, A. G., Robberecht, W., Andersen, P. M., Melki, J., Meininger, V., Hardiman, O., Landers, J. E., Brown, R. H., Jr., Shatunov, A., Shaw, C. E., Leigh, P. N., Al-Chalabi, A., Ophoff, R. A., van den Berg, L. H., and Veldink, J. H. (2012) Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS, PLoS One 7, e35333.
  42. Diagnosis, E. T. F. o., Management of Amyotrophic Lateral, S., Andersen, P. M., Abrahams, S., Borasio, G. D., de Carvalho, M., Chio, A., Van Damme, P., Hardiman, O., Kollewe, K., Morrison, K. E., Petri, S., Pradat, P. F., Silani, V., Tomik, B., Wasner, M., and Weber, M. (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force, European journal of neurology : the official journal of the European Federation of Neurological Societies 19, 360-375.
  43. Byrne, S., Elamin, M., Bede, P., Shatunov, A., Walsh, C., Corr, B., Heverin, M., Jordan, N., Kenna, K., Lynch, C., McLaughlin, R. L., Iyer, P. M., O'Brien, C., Phukan, J., Wynne, B., Bokde, A. L., Bradley, D. G., Pender, N., Al-Chalabi, A., and Hardiman, O. (2012) Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study, Lancet neurology 11, 232-240.
  44. Byrne, S., Elamin, M., Bede, P., and Hardiman, O. (2012) Absence of consensus in diagnostic criteria for familial neurodegenerative diseases, J Neurol Neurosurg Psychiatry 83, 365-367.
  45. Bede, P., Bokde, A. L., Byrne, S., Elamin, M., Fagan, A. J., and Hardiman, O. (2012) Spinal cord markers in ALS: diagnostic and biomarker considerations, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 13, 407-415.
  46. Andersen, P. M., Abrahams, S., Borasio, G. D., de Carvalho, M., Chio, A., Van Damme, P., Hardiman, O., Kollewe, K., Morrison, K. E., Petri, S., Pradat, P. F., Silani, V., Tomik, B., Wasner, M., and Weber, M. (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force, European journal of neurology : the official journal of the European Federation of Neurological Societies 19, 360-375.
  47. Prvulovic, D., Bokde, A. L., Faltraco, F., Hampel, H., O'Dwyer, L., Lamberton, F., Bokde, A. L., Ewers, M., Faluyi, Y. O., Tanner, C., Mazoyer, B., O'Neill, D., Bartley, M., Collins, D. R., Coughlan, T., Prvulovic, D., Hampel, H., Bede, P., Bokde, A. L., Byrne, S. C., Elamin, M., Walsh, R. J., Hardiman, O., Ewers, M., Walsh, C., Trojanowski, J. Q., Shaw, L. M., Petersen, R. C., Jack, C. R., Jr., Feldman, H. H., Bokde, A. L., Alexander, G. E., Scheltens, P., Vellas, B., Dubois, B., Weiner, M., and Hampel, H. (2011) Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease. Prog Neurobiol 95, 557-569.
  48. Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., and Zoing, M. C. (2011) Amyotrophic lateral sclerosis, Lancet 377, 942-955.
  49. Hardiman, O., van den Berg, L. H., and Kiernan, M. C. (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis, Nature reviews. Neurology 7, 639-649.
  50. Hardiman, O. (2011) Management of respiratory symptoms in ALS, Journal of neurology 258, 359-365.
  51. Hardiman, O. (2011) Amyotrophic lateral sclerosis and vascular risk: a metabolic conundrum, J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):591.
  52. Byrne, S., Walsh, C., Lynch, C., Bede, P., Elamin, M., Kenna, K., McLaughlin, R., and Hardiman, O. (2011) Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis, J Neurol Neurosurg Psychiatry 82, 623-627.
  53. Byrne, S., Bede, P., Elamin, M., Kenna, K., Lynch, C., McLaughlin, R., and Hardiman, O. (2011) Proposed criteria for familial amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 12, 157-159.
  54. Beghi, E., Chio, A., Couratier, P., Esteban, J., Hardiman, O., Logroscino, G., Millul, A., Mitchell, D., Preux, P. M., Pupillo, E., Stevic, Z., Swingler, R., Traynor, B. J., Van den Berg, L. H., Veldink, J. H., and Zoccolella, S. (2011) The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 12, 1-10.
  55. Bede, P., Oliver, D., Stodart, J., van den Berg, L., Simmons, Z., D, O. B., Borasio, G. D., and Hardiman, O. (2011) Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives, J Neurol Neurosurg Psychiatry 82, 413-418.
  56. Bede, P., Bokde, A. L., Byrne, S. C., Elamin, M., Walsh, R. J., and Hardiman, O. (2011) Waterskier's Hirayama syndrome, Journal of neurology 258, 2078-2079.
  57. Barry, H., Hardiman, O., Healy, D. G., Keogan, M., Moroney, J., Molnar, P. P., Cotter, D. R., and Murphy, K. C. (2011) Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis, The British journal of psychiatry : the journal of mental science 199, 508-509.